Preoperative Nomogram Predicting 12-Year Probability of Metastatic Renal Cancer

Jemal, 2007, Cancer statistics, 2007, CA Cancer J Clin, 57, 43, 10.3322/canjclin.57.1.43 Motzer, 1996, Renal-cell carcinoma, N Engl J Med, 335, 865, 10.1056/NEJM199609193351207 Leibovich, 2006, Surgical management of renal cell carcinoma, Semin Oncol, 33, 552, 10.1053/j.seminoncol.2006.06.007 Nguyen, 2006, The evolving presentation of renal carcinoma in the United States: trends from the Surveillance, Epidemiology, and End Results program, J Urol, 176, 2397, 10.1016/j.juro.2006.07.144 Chawla, 2006, The natural history of observed enhancing renal masses: meta-analysis and review of the world literature, J Urol, 175, 425, 10.1016/S0022-5347(05)00148-5 Rabinovitch, 1994, Patterns of failure following surgical resection of renal cell carcinoma: implications for adjuvant local and systemic therapy, J Clin Oncol, 12, 206, 10.1200/JCO.1994.12.1.206 1999, Interferon-alpha and survival in metastatic renal carcinoma: early results of a randomised controlled trial, Lancet, 353, 14, 10.1016/S0140-6736(98)03544-2 Kattan, 2001, A postoperative prognostic nomogram for renal cell carcinoma, J Urol, 166, 63, 10.1016/S0022-5347(05)66077-6 Lam JS, Shvarts O, Leppert JT, Pantuck AJ, Figlin RA and Belldegrun AS: Postoperative surveillance protocol for patients with localized and locally advanced renal cell carcinoma based on a validated prognostic nomogram and risk group stratification system. J Urol 174: 466. Patard, 2004, Use of the University of California Los Angeles integrated staging system to predict survival in renal cell carcinoma: an international multicenter study, J Clin Oncol, 22, 3316, 10.1200/JCO.2004.09.104 Shuch, 2006, Prognostic factors in renal cell carcinoma, Semin Oncol, 33, 563, 10.1053/j.seminoncol.2006.06.006 Zisman, 2001, Improved prognostication of renal cell carcinoma using an integrated staging system, J Clin Oncol, 19, 1649, 10.1200/JCO.2001.19.6.1649 Frank, 2002, An outcome prediction model for patients with clear cell renal cell carcinoma treated with radical nephrectomy based on tumor stage, size, grade and necrosis: the SSIGN score, J Urol, 168, 2395, 10.1016/S0022-5347(05)64153-5 Wehle, 2004, Conservative management of incidental contrast-enhancing renal masses as safe alternative to invasive therapy, Urology, 64, 49, 10.1016/j.urology.2004.02.026 Janzen, 2002, Minimally invasive ablative approaches in the treatment of renal cell carcinoma, Curr Urol Rep, 3, 13, 10.1007/s11934-002-0005-8 Cindolo, 2005, Comparison of predictive accuracy of four prognostic models for nonmetastatic renal cell carcinoma after nephrectomy: a multicenter European study, Cancer, 104, 1362, 10.1002/cncr.21331 Linehan, 2004, Genetic basis of cancer of the kidney: disease-specific approaches to therapy, Clin Cancer Res, 10, 6282S, 10.1158/1078-0432.CCR-050013 Srinivasan, 2005, Targeted for destruction: the molecular basis for development of novel therapeutic strategies in renal cell cancer, J Clin Oncol, 23, 410, 10.1200/JCO.2005.09.907 Motzer, 2006, Sunitinib in patients with metastatic renal cell carcinoma, JAMA, 295, 2516, 10.1001/jama.295.21.2516 Divgi, 2007, Preoperative characterisation of clear-cell renal carcinoma using iodine-124-labelled antibody chimeric G250 (124I-cG250) and PET in patients with renal masses: a phase I trial, Lancet Oncol, 8, 304, 10.1016/S1470-2045(07)70044-X